Baxter International (BAX) Liabilities and Shareholders Equity (2009 - 2026)

Baxter International (BAX) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $19.8 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 6.84% year-over-year to $19.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $82.0 billion (down 18.05% YoY) and the FY2025 annual result came in at $20.1 billion, down 22.21% from the prior year.
• Liabilities and Shareholders Equity retreated to $19.8 billion in Q1 2026 per BAX's latest filing, from $20.1 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $32.7 billion in Q1 2022 and bottomed at $19.8 billion in Q1 2026.
• The 5-year median for Liabilities and Shareholders Equity is $27.8 billion (2024), against an average of $26.2 billion.
• The widest annual swing landed in 2022, when Liabilities and Shareholders Equity jumped 68.07%; it then fell 23.33% in 2025.
• Tracing BAX's Liabilities and Shareholders Equity over 5 years: stood at $28.3 billion in 2022, then retreated by 0.04% to $28.3 billion in 2023, then declined by 8.82% to $25.8 billion in 2024, then decreased by 22.21% to $20.1 billion in 2025, then retreated by 1.04% to $19.8 billion in 2026.
• Per Business Quant, the three latest BAX Liabilities and Shareholders Equity figures stand at $19.8 billion (Q1 2026), $20.1 billion (Q4 2025), and $21.1 billion (Q3 2025).

Peer Comparison